Projects per year
Personal profile
Biography
Dr. Vivek Gupta is an Associate Professor and Head of the Vision Science group at Macquarie University. A recipient of both NHMRC Dementia Leadership and Career Development Fellowships, he is a neurobiologist whose research centers on the mechanisms of retinal neurodegeneration in various diseases.
His diverse research background spans cell and molecular biology, cloning and transgenic mouse models, biochemistry, clinical studies, public health and data analysis, yeast and mammalian genomics, pharmacological compound development and testing, visual electrophysiology, and gene therapy. He has cultivated a broad collaborative network across Australia, India, the USA, and Europe.
Dr. Gupta's group uses the retina as a model to investigate mechanisms underlying retinal disorders like glaucoma and macular degeneration, as well as neurodegenerative conditions such as Alzheimer's disease. His research also explores retinal and optic nerve changes, correlating them with brain imaging and neuropsychological parameters in healthy aging and Alzheimer's patients. He is actively involved in targeted retinal gene therapy studies, aiming to modulate signaling pathways and protect neurons in disease states.
Following extensive postdoctoral training in Switzerland and the USA, Dr. Gupta has secured competitive grants and published over 170 articles. His recent work has identified the pathological accumulation of amyloid beta protein in the retina in Alzheimer's disease and glaucoma, including in human post-mortem tissue.
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Novel Protective Effects of Neuropeptide Y for Glaucoma Retina
Basavarajappa, D. (Primary Chief Investigator), Chitranshi, N. (Chief Investigator), Raniga, A. (Chief Investigator), Viswanathan, D. (Chief Investigator), Gupta, V. (Co-Investigator) & Graham, S. L. (Co-Investigator)
1/01/25 → 30/06/26
Project: Research
-
AI-Enhanced CT Image Analysis for Precise Measurement of Bone Union and Healing in Jaw Reconstruction
Beheshti, A. (Primary Chief Investigator), Clarke AM, J. (Partner Investigator), Mukherjee, P. (Chief Investigator), Qi, Y. (Chief Investigator) & Gupta, V. (Chief Investigator)
1/10/24 → 31/12/25
Project: Research
-
Retinoid-X-receptor Agonists as Novel Neuroprotectants in Glaucoma
Graham, S. L. (Primary Chief Investigator), Gupta, V. (Chief Investigator) & Chitranshi, N. (Chief Investigator)
1/07/23 → 30/06/26
Project: Research
-
Let there be light- Modified Serpin as a Dual Function Therapeutic Agent in Glaucoma
Gupta, V. (Primary Chief Investigator), Graham, S. L. (Chief Investigator), Rajala, R. V. S. (Chief Investigator), Gupta, V. B. (Chief Investigator), Komaromy, A. (Chief Investigator), Mirzaei, M. (Chief Investigator) & Chitranshi, N. (Associate Investigator)
1/05/23 → 30/04/27
Project: Research
-
UNSW led: Vascular Contributions to Dementia (VCD-CRE) - a transformative approach to reducing the burden of cognitive disorders
Sachdev, P. (Chief Investigator), Parsons, M. W. (Chief Investigator), Brodtmann, A. (Chief Investigator), Levi, C. R. (Chief Investigator), Samaras, K. (Chief Investigator), Kovacic, J. (Chief Investigator), O'Sullivan, M. (Chief Investigator), Butcher, K. (Chief Investigator), Bivard, A. (Chief Investigator) & Gupta, V. (Primary Chief Investigator)
9/06/22 → 31/10/26
Project: Research
-
Correlations between postmortem quantitative MRI parameters and demyelination, axonal loss and gliosis in multiple sclerosis: a systematic review and meta-analysis
Shen, T., Sheriff, S., Qu, Y., Gupta, V. K., Graham, S. L., Klistorner, A., Jia, H., Sun, X. & You, Y., Apr 2025, In: Brain Imaging and Behavior. 19, 2, p. 323-335 13 p.Research output: Contribution to journal › Article › peer-review
-
Glial and immune dysregulation in glaucoma independent of retinal ganglion cell loss: a human post-mortem histopathology study
Salkar, A., Palanivel, V., Basavarajappa, D., Mirzaei, M., Schulz, A., Yan, P., Gupta, V., Graham, S. & You, Y., 28 Jun 2025, In: Acta Neuropathologica Communications. 13, 1, p. 1-16 16 p., 141.Research output: Contribution to journal › Article › peer-review
Open AccessFile8 Downloads (Pure) -
Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
GBD 2021 Diarrhoeal Diseases Collaborators, May 2025, In: The Lancet Infectious Diseases. 25, 5, p. 519-536 18 p.Research output: Contribution to journal › Article › peer-review
Open Access34 Citations (Scopus) -
Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
GBD 2021 Upper Respiratory Infections Otitis Media Collaborators, Jan 2025, In: The Lancet Infectious Diseases. 25, 1, p. 36-51 16 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile23 Citations (Scopus)5 Downloads (Pure) -
Retinoid X receptor agonist 9CDHRA mitigates retinal ganglion cell apoptosis and neuroinflammation in a mouse model of glaucoma
Basavarajappa, D., Chitranshi, N., Mirshahvaladi, S. S. O., Gupta, V. B., Palanivel, V., Parrilla, G. E., Salkar, A., Mirzaei, M., Komáromy, A. M., Krezel, W., Graham, S. L. & Gupta, V., 31 Mar 2025, In: FASEB Journal. 39, 6, p. 1-18 18 p., e70465.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Citation (Scopus)24 Downloads (Pure)